Skip to main content

Astle Christopher's Form 4/A amendment

Amended

Zymeworks Inc. (ZYME) · filed Dec 23, 2022

Accession no.
0000899243-22-039332
Filed
Dec 23, 2022
Trade date
Dec 12, 2022
Filing delay
11 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Dec 14, 2022

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.33K. It was filed 11 days after the trade.

This amendment replaces 0000899243-22-038516 (filed Dec 14, 2022).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Astle ChristopherCIK 0001915257Officer (SVP & Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 12, 2022Common StockMOption exerciseAcquired+1,550$0.00$02,220Direct
Dec 12, 2022Common StockSSaleDisposed−887$6.01−$5,330.871,333Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 12, 2022Common SharesMOption exerciseDisposed−1,550$0.00$01,550Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)